-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DT0t3+CiRMx6Jn9/Y6l10OHQ3CQcTIpgH/9d6CzmFY6JlFkTNulE/gAeGwvQiGXd Pav+qmyoVl5DIW3huwYQTA== 0000950156-97-000022.txt : 19970103 0000950156-97-000022.hdr.sgml : 19970103 ACCESSION NUMBER: 0000950156-97-000022 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970102 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: EV TRADITIONAL WORLDWIDE HEALTH SCIENCES FUND INC CENTRAL INDEX KEY: 0000760110 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 521378236 STATE OF INCORPORATION: MD FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 002-95103 FILM NUMBER: 97500250 BUSINESS ADDRESS: STREET 1: 24 FEDERAL STREET STREET 2: SUITE 4100 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: (617) 482-8260 MAIL ADDRESS: STREET 1: 5847 SAN FELIPE STREET 2: SUITE 4100 CITY: HOUSTON STATE: TX ZIP: 77057 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL RESEARCH INVESTMENT FUND INC DATE OF NAME CHANGE: 19920703 497 1 SUPP. DATED 1/1/97 EATON VANCE INCOME FUND OF BOSTON SUPPLEMENT TO PROSPECTUS DATED FEBRUARY 1, 1996 EV TRADITIONAL TAX-MANAGED GROWTH FUND SUPPLEMENT TO PROSPECTUS DATED MARCH 20, 1996 EV TRADITIONAL WORLDWIDE HEALTH SCIENCES FUND, INC. SUPPLEMENT TO PROSPECTUS DATED SEPTEMBER 3, 1996 1. THE FOLLOWING CHANGES RELATE TO THE PROSPECTUS OF EV TRADITIONAL WORLDWIDE HEALTH SCIENCES FUND, INC.: A. THE FOLLOWING REPLACES "ANNUAL FUND AND ALLOCATED PORTFOLIO OPERATING EXPENSES" UNDER "SHAREHOLDER AND FUND EXPENSES" ON PAGE 2 OF THE PROSPECTUS: ANNUAL FUND AND ALLOCATED PORTFOLIO OPERATING EXPENSES (as a percentage of average daily net assets) ----------------------------------------------------------------------- Management Fees (after fee reduction) 1.26% Rule 12b-1 Distribution Fees 0.25 Other Expenses 0.49 ---- Total Operating Expenses 2.00% ==== B. THE FOLLOWING IS ADDED TO "FINANCIAL HIGHLIGHTS" ON PAGE 3 OF THE PROSPECTUS: ADJUSTED FOR 100% STOCK DIVIDEND -- RECORD DATE SEPTEMBER 23, 1996 1996(1) ------------------------------ ------- NET ASSET VALUE, at beginning of year $11.71 ------ INCOME FROM INVESTMENT OPERATIONS: Net investment income (loss) (.23) Net realized and unrealized gain (loss) on investments 3.46 ------ Total from investment operations 3.23 ------ LESS DISTRIBUTIONS FROM: Net realized gain on investments 1.40 ------ NET ASSET VALUE, at end of year $13.54 ====== TOTAL RETURN(2) 31.04% RATIOS/SUPPLEMENTAL DATA Net assets at end of year (in thousands) $55,016 Ratio of operating expenses to average net assets:(3) Before expense reimbursement 2.21% After expense reimbursement N/A Ratio of net investment loss to average net assets Before expense reimbursement (1.81)% After expense reimbursement N/A Portfolio turnover rate 66% Average commission rate (per share of security)(4) $0.0864 (1)Based on average month end shares outstanding. (2)Calculated without a sales load. (3)Since September, 1989, the Adviser and prior administrator reimbursed a portion of their fees, when necessary, in order to allow the Fund to operate within the expense limitation of any state having jurisdiction over the Fund. (4)Average commission rate (per share of security) as required by amended disclosure requirements effective September 1, 1995. C. THE FOLLOWING IS ADDED TO "MANAGEMENT OF THE FUND AND THE PORTFOLIO" ON PAGE 9 OF THE PROSPECTUS: For the fiscal year ended August 31, 1996, M&I received an advisory fee of 0.97% of average daily net assets, during which time assets were managed at the Fund level. D. THE FOLLOWING IS ADDED TO "DISTRIBUTION PLAN" ON PAGE 10 OF THE PROSPECTUS: For the fiscal year ended August 31, 1996, the Fund paid distribution fees to the prior distributor of the Fund representing 0.25% of the Fund's average daily net assets. E. THE DATE OF THE PROSPECTUS IS CHANGED TO NOVEMBER 25, 1996. 2. THE FOLLOWING CHANGES RELATE TO ALL FUNDS AND ARE EFFECTIVE JANUARY 1, 1997: A. THE FOOTNOTE IN "SHAREHOLDER AND FUND EXPENSES" RELATING TO THE CONTINGENT DEFERRED SALES CHARGE IS REPLACED WITH THE FOLLOWING: No sales charge is payable at the time of purchase on investments of $1 million or more. However, a contingent deferred sales charge of 1% will be imposed on such investments in the event of certain redemptions within 12 months of purchase. See "How to Buy Fund Shares" and "How to Redeem Fund Shares." B. THE LAST LINE OF AND THE FOOTNOTES TO THE CURRENT SALES CHARGE AND DEALER COMMISSIONS TABLE UNDER "HOW TO BUY FUND SHARES" ARE REPLACED WITH THE FOLLOWING:
SALES CHARGE AS SALES CHARGE AS DEALER COMMISSION % OF AMOUNT % OF OFFERING AS PERCENTAGE OF AMOUNT OF PURCHASE INVESTED PRICE OFFERING PRICE ------------------ --------------- --------------- ----------------- $1,000,000 or more 0.00* 0.00* See below** *No sales charge is payable at the time of purchase of investments of $1,000,000 or more. A contingent deferred sales charge ("CDSC") of 1% will be imposed on such investments in the event of certain redemptions within 12 months of purchase. Such purchases made before January 1, 1997 will be subject to a CDSC of 0.50% in the event of such redemptions. **A commission on sales of $1 million or more will be paid as follows: 1.00% on amounts of $1 million or more but less than $3 million, plus 0.50% on amounts from $3 million but less than $5 million; plus 0.25% on amounts of $5 million or more. Purchases of $1 million or more will be aggregated over a 12-month period for purposes of determining the commission to be paid.
C. THE FOLLOWING IS ADDED TO "HOW TO BUY FUND SHARES": No sales charge is payable at the time of purchase where the amount invested represents redemption proceeds from a mutual fund unaffiliated with Eaton Vance if the redemption occurred no more than 60 days prior to the purchase of Fund shares and the redeemed shares were subject to a sales charge. A CDSC of 0.50% will be imposed on such investments in the event of certain redemptions within 12 months of purchase and the Authorized Firm will be paid a commission on such sales of 0.50% of the amount invested. D. THE FOLLOWING REPLACES THE FIRST SENTENCE OF THE SEVENTH PARAGRAPH (FOR TAX-MANAGED GROWTH FUND), THE FIRST AND SECOND SENTENCES OF THE SIXTH PARAGRAPH (FOR INCOME FUND OF BOSTON) AND THE FIRST SENTENCE OF THE EIGHTH PARAGRAPH (FOR HEALTH SCIENCES FUND) UNDER "HOW TO REDEEM FUND SHARES": As described under "How to Buy Fund Shares," certain purchases of Fund shares are subject to a CDSC if redeemed within 12 months of purchase. January 1, 1997 T-IBTGPS
-----END PRIVACY-ENHANCED MESSAGE-----